Abstract
Purpose
Assessing the efficacy of treatment modalities for diabetic retinopathy (DR) from the patient’s perspective is restricted due to a lack of a comprehensive patient-reported outcome measure. We are developing a DR-specific quality of life (QoL) item bank, and we report here on the qualitative results from the first phase of this project.
Methods
Eight focus groups and 18 semi-structured interviews were conducted with 57 patients with DR. The sessions were transcribed verbatim and iteratively analysed using the constant comparative method and NVIVO software.
Results
Participants had a median age of 58 years (range 27–83 years). Twenty-seven (47%) participants had proliferative DR in the better eye, and 14 (25%) had clinically significant macular oedema. Nine QoL domains were identified, namely visual symptoms, ocular surface symptoms, vision-related activity limitation, mobility, emotional well-being, health concerns, convenience, social, and economic. Participants described many vision-related activity limitations, particularly under challenging lighting conditions; however, socioemotional issues were equally important. Participants felt frustrated due to their visual restrictions, concerned about further vision loss and had difficulty coping with this uncertainty. Restrictions on driving were pervasive, affecting transport, social life, relationships, responsibilities, work and independence.
Conclusions
Patients with DR experience many socioemotional issues in addition to vision-related activity limitations. Data from this study will be used to generate data for a DR-specific QoL item bank.
Similar content being viewed by others
Abbreviations
- DME:
-
Diabetic macular oedema
- DR:
-
Diabetic retinopathy
- PRO:
-
Patient-reported outcome measure
- QoL:
-
Quality of life
References
Kocur, I., & Resnikoff, S. (2002). Visual impairment and blindness in Europe and their prevention. British Journal of Ophthalmology, 86(7), 716–722.
Cheung, N., & Wong, T. (2009). Diabetic retinopathy and systemic complications. In E. Duh (Ed.), Diabetic retinopathy (pp. 465–482). New Jersey: Humana Press.
Wong, T., & Klein, K. (2008). The epidemiology of eye diseases in diabetes. In J. Ekoé, et al. (Eds.), The epidemiology of diabetes mellitus (2nd ed., pp. 475–497). Oxford: Wiley.
Frank, R. N. (2004). Diabetic retinopathy. New England Journal of Medicine, 350(1), 48–58.
Cheung, N., Mitchell, P., & Wong, T. (2010). Diabetic retinopathy. Lancet, 376(9735), 124–136.
Penn, J. S., et al. (2008). Vascular endothelial growth factor in eye disease. Progress in Retinal and Eye Research, 27(4), 331–371.
Nicholson, B. P., & Schachat, A. P. (2010). A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology, 248(7), 915–930.
Simo, R., & Hernandez, C. (2008). Intravitreous anti-VEGF for diabetic retinopathy: Hopes and fears for a new therapeutic strategy. Diabetologia, 51(9), 1574–1580.
Lamoureux, E. L., et al. (2010). Impact of diabetic retinopathy on vision-specific function. Ophthalmology, 117(4), 757–765.
Lamoureux, E. L., Hassell, J. B., & Keeffe, J. E. (2004). The impact of diabetic retinopathy on participation in daily living. Archives of Ophthalmology, 122(1), 84–88.
Cusick, M., et al. (2005). Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. American Journal of Ophthalmology, 139(6), 1042–1050.
Lloyd, A., et al. (2008). Health utility values associated with diabetic retinopathy. Diabetic Medicine, 25(5), 618–624.
Fenwick, E., et al. (2010). The impact of diabetic retinopathy: Understanding the patient’s perspective. British Journal of Ophthalmology, 95(6), 774–782.
Fenwick, E., et al. (2011). Social and emotional impact of diabetic retinopathy: A review. Clinical and Experimental Ophthalmology (Epub ahead of print).
Devenney, R., O’Neil, S. (2010). The experience of diabetic retinopathy: A qualitative study. British Journal of Health Psychology (Epub ahead of print).
Coyne, K. S., et al. (2004). The impact of diabetic retinopathy: Perspectives from patient focus groups. Family Practice, 21(4), 447–453.
Woodcock, A., et al. (2004). The influence of diabetic retinopathy on quality of life: Interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Education and Counseling, 53(3), 365–383.
Oehlergiarratana, J., & Fitzgerald, R. G. (1980). Group-therapy with blind diabetics. Archives of General Psychiatry, 37(4), 463–467.
Scanlon, P. H., et al. (2006). Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy. Diabetic Medicine, 23(1), 60–66.
Brose, L., & Bradley, C. (2009). Psychometric development of the individualized Retinopathy-Dependent Quality of Life Questionnaire (RetDQoL). Value Health, 14(6), 740–754.
Bradley, C., et al. (1999). The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: The ADDQoL. Quality of Life Research, 8(1–2), 79–91.
Gothwal, V., et al. (2011). Multiplicative rating scales do not enable measurement of vision-related quality of life. Clinical and Experimental Ophthalmology, 94(1), 52–62.
Fung, C. H., & Hays, R. D. (2008). Prospects and challenges in using patient-reported outcomes in clinical practice. Quality of Life Research, 17(10), 1297–1302.
Lohr, K., & Zebrack, B. (2009). Using patient-reported outcomes in clinical practice: Challenges and opportunities. Quality of Life Research, 18(1), 99–107.
Lohr, K. N. (1992). Applications of health status assessment measures in clinical practice: Overview of the third conference on advances in health status assessment. Medical Care, 30(5), MS1–MS14.
Pesudovs, K., et al. (2007). The development, assessment, and selection of questionnaires. Optometry and Vision Science, 84(8), 663–674.
Pesudovs, K., Garamendi, E., & Elliott, D. B. (2006). The Contact Lens Impact on Quality of Life (CLIQ) Questionnaire: development and validation. Investigative Ophthalmology & Visual Science, 47(7), 2789–2796.
Benarous, R., et al. (2011). Differential association of serum lipids with diabetic retinopathy and diabetic macular edema. Investigative Ophthalmology & Visual Science (in press).
Dirani, M., et al. (2011). Are obesity and anthropometry risk factors for diabetic retinopathy? The Diabetes Management Project (DMP). Investigative Ophthalmology & Visual Science (Epub ahead of print).
Early Treatment Diabetic Retinopathy Study Research Group. (1991). Grading diabetic retinopathy from stereoscopic color fundus photographs- an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology, 98(5 suppl).
International Clinical Classification of Diabetic Retinopathy Severity of Macular Oedema. (2002). American Academy of Ophthalmology.
Marshall, M. (1996). Sampling for qualitative research. Family Practice, 13(6), 522–525.
Maykut, P., & Morehouse, R. (1994). Beginning qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage.
Rice, P., & Ezzy, D. (1999). Qualitative research methods: A health focus. Oxford: Oxford University Press.
Vaughn, S., Schumm, J., & Sinagub, J. (1996). Focus group interviews in education and psychology. California: Sage.
Wilkinson, S. (2004). Focus group research. In D. Silverman (Ed.), Qualitative research: Theory, method, practice (pp. 177–199). London: Sage.
Parrot, W. (2001). Emotions in social psychology. Philadelphia: Psychology Press.
Thoits, P. A. (1986). Social support and coping assistance. Journal of Consulting and Clinical Psychology, 54(4), 416–423.
Kessler, R. C., Price, R. H., & Wortman, C. B. (1985). Social-factors in psychopathology—Stress, social support, and coping processes. Annual Review of Psychology, 36, 531–572.
Holahan, C. J., et al. (1995). Social support, coping, and depressive symptoms in a late-middle-aged sample of patients reporting cardiac illness. Health Psychology, 14(2), 152–163.
Broman, A. T., et al. (2002). The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: Proyecto VER. Investigative Ophthalmology & Visual Science, 43(11), 3393–3398.
Gabrielian, A., et al. (2010). The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life. Eye, 24(1), 29–35.
Owsley, C., et al. (2007). Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology, 114(9), 1728–1735.
Owsley, C., et al. (2006). Development of a questionnaire to assess vision problems under low luminance in agerelated maculopathy. Investigative Ophthalmology & Visual Science, 47(2), 528–535.
Owsley, C., et al. (2006). Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Investigative Ophthalmology & Visual Science, 47(4), 1310–1318.
Lamoureux, E. L., et al. (2007). Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma? Optometry and Vision Science, 84(8), 789–796.
Mangione, C. M., et al. (2001). Development of the 25-item national eye institute visual function questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.
Lamoureux, E. L., et al. (2007). The Impact of Vision Impairment questionnaire: An assessment of its domain structure using confirmatory factor analysis and Rasch analysis. Investigative Ophthalmology & Visual Science, 48(3), 1001–1006.
Ware, J. E., Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.
Pesudovs, K. (2010). Item banking: A generational change in patient-reported outcome measurement. Optometry and Vision Science, 87(4), 1–9.
Revicki, D. A., & Cella, D. F. (1997). Health status assessment for the twenty-first century: Item response theory, item banking and computer adaptive testing. Quality of Life Research, 6(6), 595–600.
Forkmann, T., et al. (2009). Development of an item bank for the assessment of depression in persons with mental illnesses and physical diseases using Rasch analysis. Rehabilitation Psychology, 54(2), 186–197.
Gershon, R. C. (2005). Computer adaptive testing. Journal of Applied Measurement, 6(1), 109–127.
Acknowledgments
CERA receives Operational Infrastructure Support from the Victorian Government.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Appendix: moderator’s guide for the focus group and interview discussions
Appendix: moderator’s guide for the focus group and interview discussions
Warm up questions
Let’s start by getting to know each other. Let’s go around the group. Briefly, please let us know your name and how long you have had diabetes.
Questions and prompts
We are interested today in your diabetic eye problems and how they impact on your life.
Symptoms
First, what are some of the symptoms you experience as a result of your diabetic eye problems?
Can you describe your eyesight/vision?
How well can you see?
What factors influence your vision?
Impact on QoL
How do your eye problems impact on your QoL?
What areas of your life are affected by your diabetic eye problems?
How much would you say your diabetic eye problems impact on your QoL?
What things are harder to do because of vision loss from your diabetic eye problems?
Can you think of specific examples where your diabetic eye problem has caused you or someone else difficulty?
Do you need help from others for some things because of your eye problems?
Depending on responses so far
In other groups I have talked to many people about how their diabetic eye problems affect them emotionally. I’m interested in your experience of this.
Can you describe how your diabetic eye problems make you feel emotionally?
How do you feel about your eye problems?
Can you describe some of your emotional reactions to vision loss?
In what ways do your diabetic eye problems affect your social or family life?
What things are you missing out on because of your vision?
What social occasions or leisure activities are affected by your vision loss?
How has your eye problem affected your family and personal relationships?
Thinking about travelling and getting out and about, can you describe how your diabetes eye problems have affected this?
What things are most difficult when travelling outside or in crowded places?
What do you find difficult when moving about in your own home?
In what ways have your diabetic eye problems impacted on your work life?
What aspects of your work are harder to do?
How have your diabetic eye problems impacted on you financially?
What things have cost you money because of your diabetic eye problems?
How about managing your diabetes? In what ways do your diabetic eye problems affect this?
What things [e.g. insulin shots, glucose monitoring, exercise] are hard to do because of your vision loss?
Finally, what is the worst thing about having diabetic eye disease?
What do you find the most annoying about your vision loss from diabetes?
Thank you all very much for sharing your experiences. I know this can be a difficult area to discuss but your input has been really valuable. Before we move on, I will briefly summarise what we have discussed so far….
Is there anything else you’d like to add to this before we move on?
Treatment and impact
I’d now like to move on to talk about eye treatments.
Has anyone had any treatment for their diabetic eye problems? What was it?
What were your experiences with this treatment?
What side effects, if any, have you experienced?
In what ways has your treatment experience affected your QoL?
Useful prompts to use throughout the focus group:
Are there any other views on this?
Is there anything else?
Would you explain further?
Can you give me an example of what you mean?
Summary
We are reaching the end of our time now. I would like to summarise the key ideas that I have heard….
Is there anything I have missed or that you would like to add to my summary?
Rights and permissions
About this article
Cite this article
Fenwick, E.K., Pesudovs, K., Khadka, J. et al. The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project. Qual Life Res 21, 1771–1782 (2012). https://doi.org/10.1007/s11136-012-0110-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-012-0110-1